The global respiratory tract infection treatment market is estimated to be valued at US$ 103.19 Mn in 2024 and is expected to exhibit a CAGR of 7.1% over the forecast period 2024 to 2031.
Key players operating in the respiratory tract infection treatment market are Abbott Laboratories, AstraZeneca, Plc, Abbvie Inc., Boehringer Ingelheim GmbH, Cipla Pharmaceutical Company, GlaxoSmithKline plc,...
Respiratory tract infections majorly include conditions like pneumonia, bronchitis and the common cold characterized by inflammation of the nasal passages, sinuses, pharynx, larynx, or lower respiratory tract. A significant rise in respiratory tract infections has been witnessed in recent times owing to factors like sedentary lifestyles, rising air pollution and declining immunity. The...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian